医学
2型糖尿病
血糖性
入射(几何)
糖尿病
安全概况
联合疗法
重症监护医学
低血糖
内科学
药理学
1型糖尿病
作者
Xiaomei Wang,Jiali Qin,Yang Liu,Xianying Wang
摘要
Among the three fixed-ratio combination products, IDegLira appears most effective for glycemic control (in terms of HbA1c and FPG reduction), whereas IDegAsp demonstrates the best safety profile regarding incidence of TEAEs.
科研通智能强力驱动
Strongly Powered by AbleSci AI